Code | WIPO/GC/COVID-19/GE/22 |
Date et lieu | 5 mai 2022 (Genève, Suisse) En présentiel |
Liens | WIPO Virtual Workshop examines “The Determinants of COVID-19 Vaccine Development Success” study during its launch: English |
Thème(s) | Ateliers et séminaires |
![WIPO/GC/COVID-19/GE/22](https://www.wipo.int/edocs/mlnkdocs/en/wipo_gc_covid_19_ge_22/wipo_gc_covid_19_ge_22_mlnkdocs_572100-img1.png)
Code | WIPO/GC/COVID-19/GE/22 |
Date et lieu | 5 mai 2022 (Genève, Suisse) En présentiel |
Liens | WIPO Virtual Workshop examines “The Determinants of COVID-19 Vaccine Development Success” study during its launch: English |
Thème(s) | Ateliers et séminaires |
Code | Titre(s) | Fichier(s) | |
---|---|---|---|
WIPO/GC/COVID-19/GE/22/1 PROV. | English | Provisional Agenda | ![]() |
Titre(s) | Fichier(s) | ||
---|---|---|---|
WIPO/GC/COVID-19/GE/22/P1 | English | Presentation – Prof. Rena Conti | ![]() |
WIPO/GC/COVID-19/GE/22/P2 | English | Presentation – Ms. Shanelle Hall | ![]() |
WIPO/GC/COVID-19/GE/22/P3 | English | Presentation – Prof. Axel Metzger | ![]() |
WIPO/GC/COVID-19/GE/22/P5 | English | Presentation – Mr. Martin Friede | ![]() |
WIPO/GC/COVID-19/GE/22/P6 | English | Presentation – Ms. Deborah King (PDF) See also: Covid-19 vaccines report from the Wellcome Trust (HTML) | ![]() ![]() |
WIPO/GC/COVID-19/GE/22/WWW/572491 | English | Study by Rena Conti and comments by Shanelle Hall and Axel Metzger - The Determinants of COVID-19 Vaccine Development Success | ![]() |